We are fast growing company with a wide range of Pharmaceutical Products 


Members Governing Board


Corporate Executives 

Director's Profile & Corporate Disclosure of Oriscon Biotech India Private Limited



P. R. Shrivastava      Director ( 1st )

Chairman & Managing Director

K. Kumar                   Director ( 2nd )

Joint Director

J. Sah                          Director

Investment committee Director

Dr. A. K. Singh          Director

Human Resources Director

M. Kumar                 Director

Welfare committee Director

Dr. B. K. Gupta         Director

Product Research Director

T. Kumar                  Outside Director

Audit Committee Member

COMPANY SECRETARY  :  M/S Arun Associates, New Delhi      

BANKERS  :    (1)   Punjab National Bank     (2)  AXIS  BANK

AUDITORS  :  M/S Jha Shailendra & Associates , Chartered Accountants 

                         MR. SHAILENDRA KUMAR JHA (FCA ).        

Company's Name

Oriscon Biotech India Private Limited.

Date Established

June 20, 2006

Mailing Address

Regd. Office : Plot No: C- 80, Ganesh Nagar,Pandav Nagar Complex, New Delhi -110092, INDIA

Authorised Capital

Rs. ( Rs. Two Crores )

Scope of Business

To manufacturing and marketing of quality pharmaceutical drugs, Institutional Supply and over-the-counter drugs under loan license facility.

Web site




( Click here )


"We are a company  registered  under the  Indian Companies Act,1956 in  the  year  2006  at  New Delhi . At  Oriscon  Biotech (I)  Pvt Ltd our  philosophy  is   to provide economically  priced  good  quality Pharmaceutical Products to the humankind  at  large.  We also believe   that there should  be no compromise  on  the  health  of  a  human being. Our vision is to become a significant  major  Pharmaceutical   Company  in India  by providing   good quality  &   affordable  economical medicine for  the  treatment of all types of life threatening diseases.

The authorised capital of the company has increased from Rs.40,00,000/-( Rupees Forty Lacs only) to Rs.2,00,00,000/- (Rupees Two crore only) by creation of 16,00,000 (Sixteen Lacs) New equity shares of Rs.10/- (Rupees Ten only) each. Consequently, Clause V of the Memorandum of Association and Article 3 (a) of the Articles of Association of the Company is proposed to be altered.

A Copy of Memorandum and Articles of Association of the Company together with the proposed alteration will be made available for inspection by the Members of the Company at its Registered office between 11:00 a.m. and 1:00 p.m. on any working day of the Company till the date of Annual General Meeting.

In terms of the provisions of Section (s) 16, 31and 94 consent of the Members is required for any alteration in Memorandum and Articles of Association of the Company. The Board recommends the Resolutions for your approval.

Under section 293(1)(d) of the Companies Act, 1956, the Board of Directors cannot except with the consent of the Company borrow moneys apart from temporary loans obtained from the Company's bankers in the ordinary course of business in excess of the aggregate of paid-up capital and free reserves of the Company, that is to say, reserves not set apart for any specific purpose.

The members of the Company at the Extra-ordinary General meeting held on April 20, 2010 by Special resolution authorised Board of Directors of the Company to borrow up to a limit of Rs. 2 crores. In view of increased volume of business envisaged in the forthcoming months, it is proposed to authorise the Board to borrow up to Rs2 crores and for this purpose approval of the members is sought under Section 293(1)(d) of the Act.